Amphastar Pharmaceuticals (AMPH) Assets Average (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Assets Average of $1.6 billion for Q1 2026, up 2.3% year-over-year from $1.6 billion in Q1 2025, and down 0.55% quarter-over-quarter from $1.6 billion in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Assets Average (2014 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Assets Average history runs 13 years deep, the most recent figure standing at $1.6 billion for Q1 2026.
- In Q1 2026, Assets Average rose 2.3% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (up 2.3% YoY), while the FY2025 annual figure was $1.6 billion, up 3.77% from the prior year.
- Assets Average for Q1 2026 stood at $1.6 billion, down from $1.6 billion in the prior quarter.
- The five-year high for Assets Average was $1.6 billion in Q4 2025, with the low at $693.9 million in Q1 2022.
- The 5-year median for Assets Average is $1.5 billion (2023), against an average of $1.3 billion.
- The sharpest annual moves came in 2023 and 2024: Assets Average jumped 108.18% in 2023, then advanced 2.13% in 2024.
- Amphastar Pharmaceuticals' Assets Average stood at $734.3 million in 2022, then surged by 108.18% to $1.5 billion in 2023, then grew by 2.13% to $1.6 billion in 2024, then advanced by 5.54% to $1.6 billion in 2025, then decreased by 0.55% to $1.6 billion in 2026.
- Business Quant data shows AMPH's Assets Average at $1.6 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Amphastar Pharmaceuticals | 933.76 Mn | 643.64 Mn | 93.47 Mn | 1.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Bn |
| Mar 31, 2026 | 1.64 Bn |
| Dec 31, 2025 | 1.65 Bn |
| Sep 30, 2025 | 1.64 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Mar 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 1.56 Bn |
| Sep 30, 2024 | 1.52 Bn |
| Jun 30, 2024 | 1.53 Bn |
| Mar 31, 2024 | 1.54 Bn |
| Dec 31, 2023 | 1.53 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.08 Bn |
| Mar 31, 2023 | 757.82 Mn |
| Dec 31, 2022 | 734.34 Mn |
| Sep 30, 2022 | 725.21 Mn |
| Jun 30, 2022 | 719.98 Mn |
| Mar 31, 2022 | 693.88 Mn |
| Dec 31, 2021 | 661.60 Mn |
| Sep 30, 2021 | 658.71 Mn |